| Title |
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
|
|---|---|
| Published in |
Clinical Cancer Research, May 2021
|
| DOI | 10.1158/1078-0432.ccr-21-0164 |
| Pubmed ID | |
| Authors |
Lucila N. Kerbauy, Nancy D. Marin, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Rafet Basar, Mark Foster, Luciana Garcia Melo, Carly C. Neal, Ethan McClain, May Daher, Ana Karen Nunez Cortes, Sweta Desai, Francesca Wei Inng Lim, Mayela Carolina Mendt, Timothy Schappe, Li Li, Hila Shaim, Mayra Shanley, Emily L. Ensley, Nadima Uprety, Pamela Wong, Enli Liu, Sonny O. Ang, Rong Cai, Vandana Nandivada, Vakul Mohanty, Qi Miao, Yifei Shen, Natalia Baran, Natalie W. Fowlkes, Ken Chen, Luis Muniz-Feliciano, Richard E. Champlin, Yago L. Nieto, Joachim Koch, Martin Treder, Wolfgang Fischer, Oswaldo Keith Okamoto, Elizabeth J. Shpall, Todd A. Fehniger, Katayoun Rezvani |
X Demographics
The data shown below were collected from the profiles of 68 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 16 | 24% |
| Germany | 4 | 6% |
| United Kingdom | 2 | 3% |
| Spain | 1 | 1% |
| Belgium | 1 | 1% |
| Russia | 1 | 1% |
| India | 1 | 1% |
| Canada | 1 | 1% |
| Australia | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 38 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 44 | 65% |
| Scientists | 15 | 22% |
| Practitioners (doctors, other healthcare professionals) | 5 | 7% |
| Science communicators (journalists, bloggers, editors) | 4 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 78 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 15% |
| Student > Ph. D. Student | 10 | 13% |
| Student > Master | 6 | 8% |
| Unspecified | 3 | 4% |
| Student > Bachelor | 3 | 4% |
| Other | 6 | 8% |
| Unknown | 38 | 49% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 13 | 17% |
| Biochemistry, Genetics and Molecular Biology | 7 | 9% |
| Medicine and Dentistry | 6 | 8% |
| Agricultural and Biological Sciences | 4 | 5% |
| Unspecified | 3 | 4% |
| Other | 5 | 6% |
| Unknown | 40 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 119. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2023.
All research outputs
#357,664
of 25,734,859 outputs
Outputs from Clinical Cancer Research
#164
of 13,301 outputs
Outputs of similar age
#10,239
of 456,573 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 174 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,301 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 174 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.